Stay updated on Avelumab and Palbociclib in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.

Latest updates to the Avelumab and Palbociclib in Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedThe site revision indicator changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check13 days agoChange DetectedA sitewide NIH notice says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.7%

- Check20 days agoChange DetectedThe PALAVY breast cancer study’s latest record reports that it is active but no longer recruiting participants. The record also includes updates to its study status and contact/location information.SummaryDifference1%

- Check27 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check47 days agoChange DetectedA new 'Find contact information' item was added and a new release note 'Revision: v3.7.0' appears, while the older 'Find Contact Information' label was removed, reflecting a small UI/text update and versioning change on the Record History page.SummaryDifference0.2%

- Check68 days agoChange DetectedA new revision v3.6.6 is added to the history and the previous revision v3.6.5 is removed, updating the page's release notes in the version history.SummaryDifference0.1%

Stay in the know with updates to Avelumab and Palbociclib in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab and Palbociclib in Breast Cancer Clinical Trial page.